Table 3 Characteristics of HD patients who died or survived 0 to 14, 15 to 30, and > 30 days after COVID-19 presentation
Latin America | North America | |||||||
|---|---|---|---|---|---|---|---|---|
Mean ± SD or N (%) | Mean ± SD or N (%) | |||||||
Parameter | Died 0 to 14 days | Died 15 to 30 days | Died > 30 days | Survived | Died 0 to 14 days | Died 15 to 30 days | Died > 30 days | Survived |
Demographics | ||||||||
Age (years) | 66.5 ± 11.2 | 65.4 ± 11.9 | 65.3 ± 11.8 | 57.5 ± 15.3 | 70.02 ± 12.35 | 68.77 ± 12.43 | 68.10 ± 12.47 | 61.96 ± 13.91 |
Male | 345 (64.7) | 185 (66.8) | 114 (56.3) | 1495 (60.1) | 967 (61.2) | 581 (58.8) | 962 (51.8) | 9343 (54.3) |
BMI (Kg/m^2) | 27 ± 6.3 | 26.5 ± 5.5 | 25.1 ± 5 | 26.2 ± 5.9 | 29.4 ± 8.3 | 29.9 ± 11.1 | 28.4 ± 7.9 | 30.1 ± 8.8 |
Vintage (years) | 5.4 ± 4.9 | 5.1 ± 5.3 | 5.0 ± 4.7 | 5.2 ± 4.8 | 4.7 ± 4.1 | 4.7 ± 3.9 | 4.3 ± 4.1 | 3.9 ± 4.1 |
Catheter exposure | ||||||||
> 90 days | 124 (23.6) | 70 (25.4) | 70 (35.2) | 430 (17.5) | 324 (20.5) | 199 (20.1) | 476 (25.6) | 3592 (20.9) |
> 120 days | 98 (18.6) | 54 (19.6) | 56 (27.1) | 326 (13.3) | 312 (19.7) | 199 (20.1) | 472 (25.4) | 3538 (20.6) |
> 180 days | 94 (17.9) | 51 (18.5) | 54 (26.1) | 301 (12.2) | 304 (19.2) | 195 (19.7) | 450 (24.2) | 3452 (20.1) |
Cause of kidney failure | ||||||||
Diabetic nephropathy | 146 (28.1) | 62 (22.5) | 55 (27.2) | 481 (19.6) | 825 (52.2) | 554 (56.1) | 1053 (56.7) | 9295 (54.0) |
Hypertensive nephrosclerosis | 60 (11.5) | 28 (10.2) | 26 (12.6) | 270 (11) | 376 (23.8) | 227 (23.0) | 473 (25.5) | 4835 (28.1) |
Other | 314 (60.4) | 186 (67.3) | 119 (60.2) | 1705 (69.4) | 379 (24.0) | 206 (20.9) | 330 (17.8) | 3043 (17.7) |
Comorbidities | ||||||||
Diabetes | 199 (39.7) | 99 (37.1) | 68 (34.5) | 645 (27.2) | 1242 (78.6) | 762 (77.1) | 1450 (78.1) | 12,471 (72.5) |
Hypertension | 184 (36.7) | 109 (40.8) | 83 (42.5) | 1032 (43.5) | 1101 (69.6) | 685 (69.3) | 1288 (69.4) | 11,518 (67.0) |
Heart failure | 4 (0.8) | 3 (1.1) | 1 (0.5) | 11 (0.4) | 423 (26.8) | 207 (21.0) | 463 (24.9) | 3201 (18.6) |
Ischemic heart disease | 4 (0.8) | 1 (0.4) | 0 (0.0) | 24 (1.0) | 409 (25.9) | 226 (22.9) | 463 (24.9) | 3174 (18.5) |
Cancer | 5 (1.0) | 3 (1.1) | 1 (0.5) | 22 (0.9) | 87 (5.5) | 52 (5.3) | 111 (6.0) | 610 (3.5) |
COPD | 1 (0.2) | 1 (0.4) | 2 (1.0) | 14 (0.6) | 185 (11.7) | 103 (10.4) | 227 (12.2) | 1504 (8.7) |
Liver disease | 3 (0.6) | 1 (0.4) | 0 (0.0) | 17 (0.7) | 184 (11.6) | 97 (9.8) | 249 (13.4) | 1770 (10.3) |
Country | ||||||||
Argentina | 185 | 97 | 100 | 1021 | ||||
Colombia | 177 | 108 | 55 | 822 | ||||
Ecuador | 158 | 70 | 51 | 629 | ||||
United States | 1581 | 988 | 1857 | 17,198 | ||||